The US speech therapy market size was valued at USD 4.13 billion in 2021. The market is projected to grow from USD 4.35 billion in 2022 to USD 6.52 billion by 2029, exhibiting a CAGR of 6.0% during the forecast period.
This information is provided by Fortune Business Insights, in its report, titled, “U.S. Speech Therapy Market, 2022-2029.”
Get Sample PDF Brochure:
Decline in Patient Visits Hindered Market Growth during COVID-19
The coronavirus outbreak little affected the marketplace. Due to the government-imposed lockdown limitations, a decrease in the number of referrals to Speech-language Pathologists (SLP) was seen in the nation during the pandemic. The adoption rate of speech language treatment among Americans was also constrained by a lack of infrastructure for virtual speech therapy.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit:
Rising Prevalence of Key Speech Disorders Led to Segmental Dominance
Based on type, the market is segmented into speech disorders, language disorders, neurological conditions, swallowing disorders, and others. The speech disorders segment held a dominant U.S. speech therapy market share in 2021.
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Fortune Business Insights™ Pvt. Ltd.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245